If approved, this could generally make it easier to
hold generic drug companies liable.
Not exact matches
The reason there's no
generic Viagra yet is because Pfizer, the
company that makes it,
holds two patents for the
drug: the first for Viagra's composition — which expired in 2012 — and the second for what's called a «method of treatment,» meaning how the
drug is used.
A federal judge in Delaware on Friday struck down key patents
held by Acorda related to Ampyra, opening the doors for
generic versions of the
drug by
companies including Mylan Inc (MYL.O) and Roxane Laboratories Inc..
Perhaps, you think that with many prominent
drugs coming off patent protection, a
generic drug company like Teva (TEVA) or our own Biovail (BVF, for the masochist within us) would be a better
holding.